Mar 31 2020
March 2020 Quick Question Summary
Our March, 2020 Quick Question, “How does your facility measure extended half-life factor VIII concentrate therapy?” drew 24 votes, reflecting the number of laboratories serving Hemophilia and Bleeding Disorders services worldwide. Here are the answers: A. One-stage clot-based FVIII assay 46% [11] B. Two-stage chromogenic FVIII assay 42% [10] C. We don’t measure, assays are […]
read more